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Abstract
Background: Early diagnosis of dengue infection is crucial for better management of the disease. Diagnostic tests
based on the detection of dengue virus (DENV) Non Structural Protein 1 (NS1) antigen are commercially available with
different sensitivities and specificities observed in various settings. Dengue is endemic in Indonesia and clinicians are
increasingly using the NS1 detection for dengue confirmation. This study described the performance of Panbio Dengue
Early NS1 and IgM Capture ELISA assays for dengue detection during our surveillance in eight cities in Indonesia as well
as the genetic diversity of DENV NS1 genes and its relationship with the NS1 detection.
Methods: The NS1 and IgM/IgG ELISA assays were used for screening and confirmation of dengue infection during
surveillance in 2010–2012. Collected serum samples (n = 440) were subjected to RT-PCR and virus isolation, in which
188 samples were confirmed for dengue infection. The positivity of the ELISA assays were correlated with the
RT-PCR results to obtain the sensitivity of the assays. The NS1 genes of 48 Indonesian virus isolates were sequenced
and their genetic characteristics were studied.
Results: Using molecular data as gold standard, the sensitivity of NS1 ELISA assay for samples from Indonesia was 56.4%
while IgM ELISA was 73.7%. When both NS1 and IgM results were combined, the sensitivity increased to 89.4%. The NS1
sensitivity varied when correlated with city/geographical origins and DENV serotype, in which the lowest sensitivity was
observed for DENV-4 (19.0%). NS1 sensitivity was higher in primary (67.6%) compared to secondary infection (48.2%). The
specificity of NS1 assay for non-dengue samples were 100%. The NS1 gene sequence analysis of 48 isolates revealed the
presence of polymorphisms of the NS1 genes which apparently did not influence the NS1 sensitivity.
Conclusions: We observed a relatively low sensitivity of NS1 ELISA for dengue detection on RT-PCR-positive dengue
samples. The detection rate increased significantly when NS1 data was combined with IgM. In our study, the low
sensitivity of NS1 antigen detection did not relate to NS1 genetic diversity. Rather, the performance of the NS1 antigen
test was affected by the infection status of patients and geographical origin of samples.
Keywords: Dengue NS1 assay evaluation, Polymorphism, Surveillance
Background
Dengue is the most important arthropod-borne viral dis-
eases in humans with a large global burden. There are an
estimated 50 million infections per year occurring across
approximately 100 countries in tropical and sub-tropical
regions in the world and potential for further spread. The
disease affects approximately 2.5 billion people living in
Southeast Asia, the Pacific, and the Americas [1,2]. Dengue
disease causes variable clinical manifestations, ranging
from an undifferentiated fever and dengue fever to the
more severe forms of the disease, Dengue Hemorrhagic
Fever (DHF) and Dengue Shock Syndrome (DSS) [3].
Dengue disease is caused by dengue virus (DENV), a
member of Flaviviridae family, with a substantial genetic
diversity shown by the presence of four serotypes (DENV-
1, -2, -3, and −4) and multiple genotypes (or subtypes)
within each serotype [4,5]. DENV is transmitted through
human-mosquito cycle by Aedes aegypti and A. albopictus
* Correspondence: sasmono@eijkman.go.id
2Eijkman Institute for Molecular Biology, Jl. Diponegoro 69, Jakarta 10430,
Indonesia
Full list of author information is available at the end of the article
© 2013 Aryati et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Aryati et al. BMC Infectious Diseases 2013, 13:611
http://www.biomedcentral.com/1471-2334/13/611
mosquito vectors. The genome consists of single-stranded
positive-sense RNA which encodes three structural (C,
prM/M, E) and seven non-structural proteins (NS1, NS2A,
NS2B, NS3, NS4A, NS4B, NS5) [1].
With the absence of licensed vaccines or specific anti-
viral therapies for dengue, patient management relies on
good supportive care. Prompt and early diagnosis of den-
gue viral infection remains crucial. Laboratory confirm-
ation is important due to difficulties in making accurate
diagnosis due to the broad spectrum of clinical presenta-
tions. Among the available dengue diagnostic tools, the
detection of virus encoded NS1 antigen has become the
basis for commercial diagnostic kits and laboratories are
increasingly using NS1 detection as the preferred diagnos-
tic test [2]. NS1 is a glycoprotein essential for viral replica-
tion and viability. Assays have been developed to diagnose
DENV infections by detection of NS1 protein in blood
during acute phase [6]. High level early viremia and NS1
antigenemia has also been associated with more severe
clinical presentations [7].
The diagnostic accuracy of commercial diagnostic assays
based on DENV NS1 antigen detection in plasma/serum
samples have been described [6,8,9]. A multi-country
evaluation study reported that the best performing NS1
assay had only a moderate sensitivity (median 64%, range
34-76%), with 100% specificity. The poor sensitivity of the
evaluated assay has been related to study sites in different
geographical regions suggesting the need for further as-
sessment [10].
Indonesia is the largest archipelago country in the world
with over 17,000 islands, inhabited by around 240 million
people. The commercial NS1 antigen detection assays
have been increasingly used and are becoming the tool of
choice among clinicians to confirm DENV infection in
Indonesia. However, only limited data on the performance
of the assays for Indonesian samples is available. We re-
port here the performance of Panbio Dengue Early NS1
ELISA and IgM ELISA diagnostic assays in the detection
of DENV infection from serum samples collected during
our dengue surveillance study conducted in eight cities
across Indonesian archipelago in 2010–2012. We also ana-
lyzed the NS1 gene sequences and amino acid polymor-
phisms in 48 DENV isolates from Indonesia to determine
their contribution to the sensitivity of the NS1 ELISA
assay.
Methods
Sample collection and detection of dengue
A total of 440 clinical samples were collected during den-
gue surveillance in 2010–2012, from hospitals and health
centers in eight provincial capital cities located in six major
islands across Indonesian archipelago, namely Jakarta
(Java), Surabaya (Java), Semarang (Java), Medan (Sumatra),
Denpasar (Bali), Kendari (Sulawesi), Jayapura (Papua) and
Samarinda (Borneo). Ethical clearances were obtained
from Medical Research Ethics Committees of Airlangga
University, Surabaya and Diponegoro University, Semarang.
Dengue-suspected febrile patients with clinically suspected
dengue based on WHO-SEARO 2011 guideline [11] were
enrolled upon obtaining written consent. Serum samples
were collected in each health centers and stored frozen
at −20°C or −80°C (depending on the availability of the
freezer in each center) prior to transport using dry-ice to
centralized laboratory at Eijkman Institute for dengue diag-
nosis and virus isolation, in which samples were then main-
tained at −80°C for long-term storage. Detection of DENV
NS1 antigen was performed using Panbio Dengue Early
ELISA (Alere, Brisbane, Australia), according to manufac-
turer’s instructions. Dengue infection was confirmed with
the results of conventional RT-PCR detection [12], SYBR
Green real-time RT-PCR [13] and/or Simplexa™ dengue
molecular assay (Focus Diagnostics, Cypress, CA), and/or
virus isolation in C6/36 cell line followed by sequencing of
the DENV NS1 gene as gold standard. To confirm the ac-
curacy of the detection results, NS1 ELISA was repeated on
NS1-negative samples. The Panbio Dengue Duo IgM &
IgG Capture ELISA (Alere) was also performed on RT-
PCR-positive samples and the resulting IgM & IgG values
were used to determine the infection status of the patients
(i.e. primary or secondary infection) according to the
manufacturer’s instruction. A total of 43 sera from pa-
tients diagnosed as having non-dengue infection (i.e. ty-
phoid, leptospirosis, measles, malaria and bacterial
septicemia) confirmed by clinical and laboratory tests
were used as non-dengue cases control. In addition, 20
healthy individual samples were also tested using the
NS1 ELISA kit.
RNA extraction and reverse transcriptase-polymerase
chain reaction (RT-PCR)
RNA extraction and PCR preparation/reaction procedures
were performed at a Good Clinical Laboratory Practice
(GCLP)-certified laboratory at the Eijkman Institute. Strict
control measures were adopted to prevent cross contam-
ination between samples. Viral RNA was extracted from
each serum sample using MagNA Pure LC Total Nucleic
Acid Isolation Kit and automated MagNa Pure LC 2.0
Instrument (Roche, Mannheim, Germany) according to
manufacturer’s instructions. DENV nucleic acid detection
and serotyping were done firstly by two steps conven-
tional RT-PCR according to protocol previously described
by Lanciotti et al. [12], with modification according to
Harris et al. [14]. Detection and serotyping were con-
firmed using SYBR Green real-time RT-PCR detection
[13] and Simplexa™ Dengue Molecular Assay performed
in 3 M Integrated Cycler machine (Focus Diagnostics).
The Simplexa Dengue assay was performed according to
the manufacturer's instructions.
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Virus isolation using cell tissue culture
The C6/36 (Aedes albopictus, mid gut) cell line [15] was
used in virus isolation. Monolayer of cells in T25 flask
(Corning, NY) was inoculated with 200 μl of sera in 2 ml of
1X RPMI medium supplemented with 2% of Fetal Bovine
Serum (FBS), 2 mM of l-glutamine, 100 U/ml of Penicillin,
and 100 μg/ml of Streptomycin (all from Gibco-Life Tech-
nologies, Carlsbad, CA). Flasks were incubated for 1 hour
at 28°C to allow virus attachment. Following the incubation
period, inoculation medium was discarded and the medium
was replenished with 3 ml of fresh medium. Infected cells
were incubated at 28°C for up to 14 days and then sub-
jected to RT-PCR detection.
DENV NS1 gene sequencing
RT-PCR positive samples were subjected to NS1 gene se-
quencing (1,056 nt). DENV RNA was reverse-transcribed
into cDNA using Superscript III reverse transcriptase (RT)
(Invitrogen-Life Technologies). The resulting cDNA was
then used as template for PCR amplification using Pfu
Turbo Polymerase (Stratagene-Agilent Technologies, La
Jolla, CA). PCR products were purified from 0.8% agarose
gel using QIAquick gel extraction kit (Qiagen, Hilden,
Germany) and used in cycle sequencing reaction per-
formed using 4 overlapping primers from both strands
and BigDye Dideoxy Terminator sequencing kits v3.1 (Ap-
plied Biosystems), using the method described by the
manufacturer. Purified DNA was subjected to capillary se-
quencing performed on 3130xl genetic analyzer (Applied
Biosystems) at the Eijkman Institute sequencing facility.
Primers used in sequencing were described elsewhere
[16]. Resulting sequence reads were assembled using
SeqScape v.2.5 (Applied Biosystems). Sequence alignment
was done using MUSCLE [17] in MEGA 5.0 software [18].
A total of 48 NS1 genes representing all serotypes were
successfully sequenced, and the sequences have been de-
posited at GenBank database (Table 1).
DENV NS1 sequence analysis
Bayesian inferences method as implemented in MrBayes
[19] was used to analyze the DENV NS1 sequences. The
summary phylogenetic trees were generated using codon,
mixed model across GTR model with gamma rate, run-
ning over 1 million generations and sampled every 1000
generations [20]. The positive selection analysis were per-
formed under NY98 model running over 100.000 gener-
ation and sampled every 100 generations [21].
Data and statistical analysis
All statistical analyses were performed using R statistical
software (http://www.r-project.org). To assess the signifi-
cance of the different results of NS1 and IgM assays, the
McNemar’s test was applied to 2x2 contingency table de-
rived from the NS1 and IgM assay results on subsets of
the data. The significance of the geographical regions,
serotype, infection status and disease severity on the re-
sults of NS1 and IgM were assessed using generalized
logistic regression as implemented in rms library from R
statistical software. We considered p-values of less than
0.05 as statistically significant.
Results
Sensitivity of NS1 and IgM tests with reference to
genome detection/virus isolation
Of 440 samples tested, 106 were positive for NS1 antigen
and 188 samples were positive by dengue genome detec-
tion and/or by virus isolation. Sensitivity of NS1 ELISA
was 56.4% when genome detection and/or virus isolation
used as the gold standard (Table 2). None of the 43 con-
firmed non-dengue cases and 20 healthy individual sam-
ples were positive by NS1 ELISA giving specificity of
100%. A total of 140 (73.7%) samples were detected posi-
tive by Panbio Dengue Duo IgM & IgG Capture ELISA. If
both NS1 and IgM positive results were combined, the de-
tection rate increased to 89.4%. As the IgG test could not
be used to distinguish between current and past dengue
infection, in this study we did not assess its performance.
Comparison of the sensitivity of NS1 test and IgM test
Table 2 showed the significance of the differences between
NS1 antigen and IgM ELISA assays as analyzed using
McNemar’s statistical test. The statistically significant dif-
ferences of the performance of both tests were observed
in Samarinda and Surabaya, as well as the total Indonesian
samples. Significant differences were also observed in
DENV-1 and DENV-4 serotypes, secondary infection sam-
ples, and samples obtained from patients with DHF.
NS1 sensitivity in relation to geographical regions, virus
serotypes, disease severity, and infection status
The NS1 sensitivity varied among confirmed dengue sam-
ples collected in different cities, ranged from 4.2% to
88.9% (Table 2). To assess the correlation between infect-
ing DENV serotypes with NS1 ELISA assay performance,
we compared the sensitivity of the assay against each
DENV serotype. As shown in Table 2, the sensitivities
of the assay were 67.4%, 68.4%, 68.8% and 19.0% for
DENV-1, -2, -3 and −4, respectively. A total of 23 out of
24 samples from Samarinda that were positive for DENV-
4 by RT-PCR, which included two mixed infections with
DENV-1 and −2 (data not shown), were negative for NS1
and contributed to the low sensitivity of the NS1 ELISA in
detecting DENV-4. Confirmation with IgM and IgG
ELISA detected 20 of them positive for dengue. Further-
more, detailed results of the regression modeling also indi-
cated that samples originated from Samarinda and the
DENV-4 were also significant factors in determining the
NS1 sensitivity (Additional file 1: Table S1).
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Table 1 DENV isolates with NS1 gene sequenced
No Sample ID City of origin Serotype GenBank accession no.
1. D1/ID/DPS-B001 Denpasar DENV-1 KF385889
2. D1/ID/DPS-B007 Denpasar DENV-1 KF385890
3. D1/ID/DPS-B015 Denpasar DENV-1 KF385891
4. D1/ID/DPS-B018 Denpasar DENV-1 KF385892
5. D1/ID/JKT-J003 Jakarta DENV-1 KF385887
6. D1/ID/JKT-J007 Jakarta DENV-1 KF385888
7. D1/ID/SMG-SE003 Semarang DENV-1 KF385905
8. D1/ID/SMG-SE058 Semarang DENV-1 KF385906
9. D1/ID/SMG-SE059 Semarang DENV-1 KF385907
10. D1/ID/SUB-0025 Surabaya DENV-1 KF385893
11. D1/ID/SUB-0031 Surabaya DENV-1 KF385894
12. D1/ID/SUB-003A Surabaya DENV-1 KF385895
13. D1/ID/SUB-026A Surabaya DENV-1 KF385896
14. D1/ID/SUB-027A Surabaya DENV-1 KF385897
15. D1/ID/SUB-032A Surabaya DENV-1 KF385898
16. D1/ID/SUB-038A Surabaya DENV-1 KF385899
17. D1/ID/SUB-048A Surabaya DENV-1 KF385900
18. D1/ID/SUB-049A Surabaya DENV-1 KF385901
19. D1/ID/SUB-117A Surabaya DENV-1 KF385902
20. D1/ID/SUB-120A Surabaya DENV-1 KF385903
21. D1/ID/SUB-141A Surabaya DENV-1 KF385904
22. D2/ID/JKT-J002 Jakarta DENV-2 KF385911
23. D2/ID/JKT-J004 Jakarta DENV-2 KF385912
24. D2/ID/MDN-M004 Medan DENV-2 KF385909
25. D2/ID/MDN-M022 Medan DENV-2 KF385910
26. D2/ID/SMG-SE001 Semarang DENV-2 KF385913
27. D2/ID/SUB-0011 Surabaya DENV-2 KF385908
28. D3/ID/DPS-B008 Denpasar DENV-3 KF385923
29. D3/ID/JKT-J013 Jakarta DENV-3 KF385926
30. D3/ID/JKT-J019 Jakarta DENV-3 KF385927
31. D3/ID/JKT-J026 Jakarta DENV-3 KF385928
32. D3/ID/KND-K013 Kendari DENV-3 KF385924
33. D3/ID/MDN-M017 Medan DENV-3 KF385925
34. D3/ID/SMG-SE005 Semarang DENV-3 KF385929
35. D3/ID/SMG-SE052 Semarang DENV-3 KF385930
36. D3/ID/SUB-0006 Surabaya DENV-3 KF385914
37. D3/ID/SUB-0019 Surabaya DENV-3 KF385915
38. D3/ID/SUB-0023 Surabaya DENV-3 KF385916
39. D3/ID/SUB-0024 Surabaya DENV-3 KF385917
40. D3/ID/SUB-0027 Surabaya DENV-3 KF385918
41. D3/ID/SUB-0030 Surabaya DENV-3 KF385919
42. D3/ID/SUB-083A Surabaya DENV-3 KF385920
43. D3/ID/SUB-114A Surabaya DENV-3 KF385921
44. D3/ID/SUB-124A Surabaya DENV-3 KF385922
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ANOVA test on logistic regression of NS1 assay results
with geographical regions/cities of origin, serotype, infec-
tion status and disease severity as cofactors indicated that
the general influential factors in determining the sensitiv-
ity of NS1 were geographical regions (p-value = 0.008) and
infection status (p-value = 0.015), as depicted in Table 3.
IgM sensitivity in relation to geographical regions, virus
serotypes, disease severity, and infection status
Although IgM sensitivity appeared to be affected by geo-
graphical regions with sensitivities ranging from 38.5% to
93.1% (Table 2), ANOVA test of logistic regression on IgM
results indicated that the infection status (p-value < 0.001)
and serotype (p-value = 0.044) were the factors that influ-
enced the IgM sensitivity as shown in Table 3.
NS1 protein sequence analysis
We successfully sequenced the NS1 genes of 48 isolates
representing all serotypes, and the sequences have been
deposited at GenBank database (Table 1). Alignments of
protein sequences of the isolates were done according to
their serotypes. Figure 1 depicts the amino-acid (AA) poly-
morphic sites of the NS1 genes with only variable AAs
shown. As seen in Figure 1, most substitutions in the NS1
gene were observed in DENV-1, in which substitutions
were observed in 30 out of 352 sites (8.5%). We revealed
substitutions in 7 sites (2.0%) for DENV-2, 22 sites (6.25%)
for DENV-3, and only 5 sites (1.4%) for DENV-4, all out
of 352 residue sites (Table 4). Further, we observed distinct
mutations that only occurred in samples with negative
NS1 results (indicated with asterisks in Figure 1) at AA
Table 1 DENV isolates with NS1 gene sequenced (Continued)
45. D4/ID/MDN-M010 Medan DENV-4 KF385934
46. D4/ID/SUB-0007 Surabaya DENV-4 KF385931
47. D4/ID/SUB-0029 Surabaya DENV-4 KF385932
48. D4/ID/SUB-0032 Surabaya DENV-4 KF385933
Table 2 Dengue detection by RT-PCR, NS1, and IgM ELISAs on samples from Indonesia
Parameter RT-PCR NS1 NS1 sensitivity (%) IgMa IgM sensitivity (%) p-valueb
City (island)
Denpasar (Bali) 13 10/13 76.9 5/13 38.5 0.131
Jakarta (Java) 9 8/9 88.9 4/9 44.4 0.221
Jayapura (Papua) 8 3/8 37.5 7/8 87.5 0.134
Kendari (Sulawesi) 3 1/3 33.3 2/3 66.7 1.000
Medan (Sumatra) 6 5/6 83.3 4/6 66.7 1.000
Samarinda (Borneo) 24 1/24 4.2 17/24 70.8 <0.001
Semarang (Java) 29 22/29 75.9 27/29 93.1 0.182
Surabaya (Java) 96 56/96 58.3 74/93 79.6 0.001
Total Indonesia 188 106/188 56.4 140/188 73.7 <0.001
Serotype
DENV-1 86 56/86 67.4 74/84 88.1 0.002
DENV-2 19 13/19 68.4 12/19 63.2 1.000
DENV-3 32 22/32 68.8 17/32 53.1 0.332
DENV-4 42 8/42 19.0 31/42 73.8 <0.001
Mix-infection 9 5/9 55.6 6/8 75.0 0.617
Infection statusa
Primary 71 48/71 67.6 40/71 56.3 0.201
Secondary 114 55/114 48.2 100/114 87.7 <0.001
Severityc
DF 59 30/59 50.8 34/58 58.6 0.486
DHF 120 72/120 60.0 97/118 82.2 <0.001
DSS 9 4/9 44.4 9/9 100 0.074
aData not available for 3 samples.
bMcNemar test; statistically significant p-values were printed in bold.
cWHO-SEARO Guidelines 2011 [11].
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residues 98(T), 101(E), 175(H), 178(A), 279(F), and 290(Q)
for DENV-1; and residues 69(R), and 168(R) for DENV-3.
The results of sequence characteristics as well as posi-
tive selection analysis are also shown in Table 4. Sites of
both DENV-1 and DENV-3 sequences were mostly under
strong constraining selection (93% and 96%, respectively),
while only small sites were under positive selection (3.7%
and 1.4%, respectively). Both DENV-2 and DENV-4 se-
quences were not being analyzed because of the inad-
equate sample size.
To assess the genetic relationship of the DENV iso-
lated in this study, we performed phylogenetic analysis
based on NS1 gene sequence. Figure 2 showed the
unrooted Bayesian inference summary tree generated by
MrBayes. The DENV-1 tree clearly showed that DENV-
1 sequences were divided into 2 major clusters and a
single strain out-group (Figure 2A). The DENV-2 tree
showed that the sequences were clumped into one cluster
(Figure 2B). The DENV-3 tree also showed similar result
as DENV-2 tree (Figure 2C). The DENV-4 tree was not
generated because of the small number of sequences.
Discussion
We report here the use of Panbio Early Dengue NS1
ELISA assay in detecting dengue infection during surveil-
lance in Indonesia in 2010–2012. This report reflected the
performance of the NS1 ELISA assay in surveillance/field
setting. We also report here the Panbio Dengue Duo IgM
ELISA performance as supporting information. Our evalu-
ation was based on the molecular detection results as gold
standard. We analyzed samples which were positive for
dengue by RT-PCR and/or virus isolation followed by NS1
gene sequencing. On these samples, NS1 antigen detec-
tion results were recorded and the positivity of the sam-
ples on NS1 antigen was compared. We observed a
number of NS1-negative samples (n = 82) which were posi-
tive by RT-PCR. In order to confirm the accuracy of the de-
tection results on those NS1-negative samples, NS1 ELISA
was repeated. Our results detected overall sensitivity of
56.4% in the NS1 assay used. This Early Dengue ELISA
NS1 assay has been previously assessed for its performance
[22]. Compared to previous reports, this sensitivity obtained
in our study was rather low. During our surveillance study,
we also used the Panbio Dengue Duo IgM & IgG ELISA.
Table 3 ANOVA result based on logistic regression of the
samples on various factors
Parameters df NS1a IgMb
χ2 p-value χ2 p-value
City of origin 7 19.21 0.008c 7.42 0.387
Serotype 4 6.60 0.159 9.78 0.044d
Infection status 1 5.92 0.015c 11.14 <0.001d
Severity 2 2.53 0.282 4.29 0.117
df: degree of freedom.
χ2: Chi-square statistics, p-value < 0.05 is considered statistically significant
(printed in bold).
aLogistic regression model:
NS1 ~ City + Serotype + Infection status + Severity.
bLogistic regression model:
IgM ~ City + Serotype + Infection status + Severity.
cOmission of samples from cities with small samples size (Kendari and Medan)
did not affect the statistical significant (p = 0.003 for city of origin and p = 0.034
for infection status).
dOmission of samples from cities with small samples size (Kendari and Medan)
did not affect the statistical significant (p = 0.034 for serotype and p < 0.001 for
infection status).
Figure 1 NS1 gene amino acid polymorphisms in Indonesian
dengue virus isolates for DENV-1 (A), DENV-2 (B), DENV-3 (C),
and DENV-4 (D). Only variable sites were shown with the
corresponding amino acid positions. Asterisks indicate the samples
that were negative for NS1 detection.
Aryati et al. BMC Infectious Diseases 2013, 13:611 Page 6 of 11
http://www.biomedcentral.com/1471-2334/13/611
The IgM ELISA detected 140 IgM-positive samples out
of 188 samples (sensitivity = 73.7%). Although the sensi-
tivity was higher for IgM assay compared to NS1 assay,
this did not necessarily indicate that IgM assay had bet-
ter sensitivity since we did not compare the duration of
illness. When both NS1 antigen and IgM-positive re-
sults were combined together, the detection rate/sensi-
tivity increased to 89.4%. The increased sensitivity of
dengue detection using combination of NS1 and IgM
has been previously reported [23-25] and our result was
in accordance with those reports.
The specificity of the NS1 assay in this study was 100%
when tested in samples confirmed for non-dengue infec-
tion and from healthy individuals. Unfortunately, because
the lack of samples confirmed for other flavivirus infec-
tion, we were not able to assess for its specificity against
other flaviviruses. Previous study has described the specifi-
city of this NS1 assay against non-dengue infection includ-
ing other flaviviruses [10].
The NS1 sensitivity was varied if samples were grouped
according to the geographical regions/cities of origin and
serotypes (Table 2). Guzman and co-workers also ob-
served the different sensitivity of NS1 assays according to
the geographical region of the patients [10]. Indonesia is
an archipelago country in which spatial barriers exists
between islands. Our samples were collected from eight
cities reside in six different major islands, thus the dif-
ferent sensitivity observed in various cities may reflect
the circulation of various serotypes and genotypes of
DENV in different geographical regions of Indonesia.
The possible differences in the background immunity of
people in each city may also contribute to the variable
sensitivity of the NS1 and IgM assays. Although we en-
sured the uniformity in the sample collection method, it
is possible that different sample handling and storage in
each region may also become other contributing factors
in regards to geographical regions. Also, we are aware
that the sample number and DENV serotype distribu-
tions according to cities were not equal, and some cities
were only represented by small sample number. This
observation warrants further confirmation on the gen-
etic diversity of DENV in Indonesia.
In term of sensitivity in relation with infection status,
the NS1 antigen assay evaluated here showed higher
sensitivity in primary infection (67.6%) compared to sec-
ondary infection (48.2%) (Table 2), supported by ANOVA
test (p-value = 0.015, Table 3). This result is in accordance
with previous reports that observed the decreased sensitiv-
ity of NS1 tests in secondary infection [26,27]. It has been
proposed that the reduced sensitivity of NS1 antigen de-
tection in secondary dengue infection occurred because
NS1 protein was sequestered in immune complexes when
a substantial level of DENV-reactive IgG was present [28].
Therefore, our NS1 result confirmed the previous findings
about the significant association of the NS1 detection and
infection status. Unlike the NS1 antigen detection, our
supporting data on the IgM detection observed higher
sensitivity in secondary infection, which is in accordance
with previous report [27]. This was also supported by the
significant result of the ANOVA test (p-value < 0.001).
Therefore, we believed that the sensitivities of both NS1
and IgM assays were affected by the infection status of
patients.
The severities of the dengue patients recruited in this
study were graded according to WHO-SEARO Guidelines
2011 classification. Most patients were DHF, followed by
DF and DSS (Table 2). A recent report described that the
circulating NS1 protein levels were higher in patients with
DHF than patients with DF [29]. In our study, when the
sensitivity of the NS1 assay was correlated with the sever-
ity, we observed quite similar rates of detection on all
grades of dengue severity (Table 2). This data demon-
strated that the performance of this NS1 assay was not in-
fluenced by disease severity. Our data also confirmed the
previous report on NS1 assays evaluation, in which no
correlation between sensitivity and disease severity was
observed [10].
In general, our results did not indicate that the DENV
serotypes contributed to the sensitivity of NS1 based on
the ANOVA test. However, we observed very low sensitiv-
ity of NS1 in samples infected by DENV-4 (Table 2), and
that DENV-4 serotype was indeed significant in influen-
cing the NS1 sensitivity (Additional file 1: Table S1). When
DENV-4 data was excluded, the overall NS1 sensitivity
Table 4 NS1 sequence characteristics and positive selection analysis results
DENV serotype DNA polymorphic site Protein polymorphic site pi (−) pi (N) pi (+)
DENV-1 (n = 21) 190 30 93.6% 2.6% 3.7%
DENV-2 (n = 6) 58 7 NA NA NA
DENV-3 (n = 17) 119 22 96.8% 1.7% 1.4%
DENV-4 (n = 4) 38 5 NA NA NA
Note:
pi (−): proportion of sites undergoing strong constraining selection.
pi (N): proportion of sites undergoing neutral selection.
pi (+): proportion of sites undergoing strong positive selection.
NA: not applicable due to inadequate sample size.
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increased to 65.7% (data not shown). Previous studies sug-
gested that sensitivity of NS1 test differed according to the
serotype, and lower NS1 sensitivity was observed for
DENV-4 [10,30,31]. Our result was in accordance with the
studies described above, but in contrast with previous ob-
servation of the NS1 rapid test sensitivity in Cambodia,
which was highly sensitive for DENV-4 [27]. It is possible
that the different genotypes of DENV contribute to the de-
tection limit of the NS1 assay. Indeed, based on molecular
phylogenetic data, the DENV-4 viruses in Cambodia and
surrounding countries such as Thailand and Vietnam were
grouped into Genotype I [32], while Indonesian DENV-4
viruses were grouped into Genotype II, based on Lanciotti
[33] classification (Sasmono et al., in preparation). Overall,
we do not know exactly why this particular serotype has
significantly low sensitivity toward NS1 assay. Unfortu-
nately, we only have limited genomic information of the
DENV-4 from our samples, hence we cannot provide bet-
ter explanation. Other factors that may impact the sensi-
tivity include different virus characteristics, higher rates of
immune complex bound antigens [28], or specimen hand-
ling and/or transport differences.
The low sensitivity of NS1 antigen detection in our sam-
ples prompted us to perform NS1 gene sequence analysis.
This was carried out to further investigate the correlation
between DENV genetic diversity and the NS1 ELISA sen-
sitivity, as well as to study the genetic variation and selec-
tion pressure of the NS1 gene. We successfully sequenced
48 NS1 genes and aligned them according to their sero-
types. The most polymorphic NS1 gene was observed for
DENV-1, followed by DENV-3, DENV-2 and DENV-4
(Table 4). We are aware that the small sample number of
DENV-2 and DENV-4 may contribute to the low poly-
morphism observed for these serotypes.
The different avidity of the anti-NS1 antibody used in
the assay against epitopes of different serotypes/genotypes
may also potentially be related to the assay’s sensitivity.
The Panbio NS1 ELISA assay is designed to detect the
NS1 antigen from all serotypes, in which the monoclonal
antibody (MAb) that was used detected common epitope
shared by all serotypes. Previous studies mapped the anti-
NS1 MAb that cross-reacted with all serotypes into com-
mon NS1 gene epitope (111LRYSWKTWGKA121) [34,35].
When we aligned the NS1 AA sequences of the 48 Indo-
nesian DENV isolates with the above epitope, we observed
the presence of 1 to 4 AA mismatches in all isolates, with
most substitutions occurred in AA 111–112 and 117
(Additional file 2: Figure S1). However, since these mis-
matches were shared by samples with both positive and
negative NS1 antigen results, these mismatches were un-
likely to influence the sensitivity of NS1 detection assay.
Further alignment of the Indonesian samples with other
proposed common epitope regions of NS1 reported by


































































































Figure 2 Unrooted Bayesian inference summary tree generated
by MrBayes with mixed model across GTR space with gamma
rates for DENV-1 (A), DENV-2 (B), and DENV-3 (C).
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had limited polymorphisms compared to the common
epitope sequences, the polymorphisms were retained on
all of the samples (Additional file 2: Figure S1). The poly-
morphisms of these epitope regions were most likely not
involved in the sensitivity of NS1 ELISA assay as the same
substitutions were occurred on majority of the samples
with either NS1 antigen negativity or positivity.
We observed 8 polymorphic positions that only occurred
in NS1 antigen negative samples. From those positions,
only one mutation (AA 168R) from a DENV-3 sample re-
sided within the proposed epitope region of AA 141 – 168.
However, we were not able to conclude whether mutations
that occurred in those polymorphic positions were indeed
affecting the results of NS1 sensitivity as those mutations
were singletons.
We analyzed the genetic relationships of the Indonesia
DENV based on the NS1 gene sequences. Other than the
commonly used E protein gene, the NS1 protein gene has
been used in the phylogenetic analysis to determine the
genotype of DENV [37]. The non-structural (NS) proteins
themselves may play an important role in DENV evolution,
particularly NS1, NS2A and NS4B proteins [38]. Our
phylogenetic analysis observed the clustering of the DENV-
1 isolates into two groups with one isolate as an out-group
(Figure 2A). This grouping was in accordance with
grouping based on E protein gene sequences classified
by Goncalvez et al. [39] (Sasmono et al., in preparation).
Therefore, it is clear that during this study, multiple geno-
types of DENV-1 were circulating in Indonesia. The pre-
dominant genotypes were the Genotype I and IV (Sasmono
et al., in preparation). We also recently discovered an iso-
late belonging to the old genotype II of DENV-1 in
Semarang [40], one of the cities involved in this study. The
patient infected by this particular strain (SMG-SE003/2012)
was negative for NS1 ELISA but positive for dengue IgM,
IgG, and RT-PCR detection [40]. The phylogenetic analysis
grouped all of DENV-2 isolates together in one group.
Similarly, DENV-3 isolates were also clustered as a single
group. The small number of DENV-4 isolates sequenced in
this study was not sufficient for the phylogenetic analysis.
However, based on the E protein sequence analysis, so far
we only discovered a single genotype of DENV-4 circulat-
ing in Indonesia (i.e. genotype II based on Lanciotti’s classi-
fication [33]) (Sasmono et al., in preparation).
Another aspect that may affect the varied sensitivity
on NS1 detection is the different magnitude of NS1 secre-
tion which appeared to be strain dependent, as recently
reported [41]. Indeed, our preliminary study detected dif-
ferent levels of NS1 expression in various strains of DENV
in vitro (data not shown). Therefore, this phenomenon
may also contribute to the varied sensitivities of the NS1
detections.
We did not detect any evidence of substantial positive
selection in the evolution of NS1 in all serotypes, as the
majority of sites were under strong negative or constraining
selection. A previous study also observed that there was no
evidence of positive selection in the structural proteins of
DENV-2 including the NS1 protein [29]. This indicates that
NS1 needs to retain its structure and amino acid sequences
to be able to perform its function effectively.
Conclusion
In summary, we observed the low sensitivity of Panbio
Early Dengue NS1 ELISA in detecting dengue infection in
samples collected during our surveillance in Indonesia.
The combination of both NS1 and IgM ELISAs increased
the detection rate. We concluded that infection status con-
tributed to the sensitivities of both NS1 and IgM assays.
Geographical regions, which might reflect on the differ-
ences of sample handling and proportion on dengue virus
serotype/genotype, were also contributed to the NS1 assay
results. Although in general the serotypes were not influen-
tial in the sensitivity of NS1 assay, our data suggested that
DENV-4 serotype was associated with the low sensitivity of
the assay. Our genetic analysis of the NS1 genes of DENV
isolates from Indonesia revealed that the observed poly-
morphisms of NS1 genes in Indonesia were less likely to
contribute to the sensitivity of NS1 ELISA. The perform-
ance of dengue diagnostic assays should be continually
assessed to ensure their accuracies in detecting dengue in-
fection, especially in different geographical regions and in-
fection status background which is eminent in dengue
endemic countries.
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